Piramal Pharma P/B Ratio

Current P/B Ratio
4.0
High Valuation
Very High - Significant premium, high growth expectations or speculative

Piramal Pharma P/B ratio. Piramal Pharma (PPLPHARMA) P/B ratio is 4.0 (High), book value per share ₹61.51 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Browse PPLPHARMA financial statements for revenue, profit, balance sheet and cash flow data.

Current Valuation Metrics

P/B Ratio 4.0
Current Price ₹239.65
Book Value/Share ₹61.51
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹8,163 Cr
Share Capital ₹1,327 Cr
Reserves & Surplus ₹6,836 Cr
Outstanding Shares 1,327,000,000
Book Value per Share ₹61.51

Valuation Signal

Signal Overvalued
Historical Avg 3.12
Historical Range 1.98 - 4.45
Percentile 80.0%

Sector Context

Sector Average -0.3
Sector Median 0.39
Sector Rank #11 of 50
Sector Percentile 22.0%

PPLPHARMA P/B Ratio — Valuation Insights & Book Value Analysis

Piramal Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 4.0 (High). For live price, earnings yield and the full fundamental profile, see PPLPHARMA screener.

  • Stock appears overvalued with PB of 4.0, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 28.3% above historical average
  • Trading at premium to sector average PB of -0.3

Piramal Pharma P/B Ratio Historical Trend

PPLPHARMA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read PPLPHARMA dividend history for the complete payout history and dividend yield track record.

PPLPHARMA Historical P/B Ratio — Book Value Per Share & Year-End Price

Piramal Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 3.9 ₹61.51 ₹239.65 ₹8,163 High
2025 2.81 ₹61.37 ₹172.21 ₹8,126 Moderate
2024 4.45 ₹59.8 ₹266.25 ₹7,911 High
2023 2.45 ₹56.78 ₹138.85 ₹6,774 Moderate
2022 1.98 ₹56.47 ₹111.95 ₹6,697 Moderate

PPLPHARMA vs Healthcare Peers — P/B Ratio Comparison

Piramal Pharma P/B 4.0 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.

Sector Average
-0.3
Sector Median
0.39
Lowest P/B
-7.62
Highest P/B
0.89
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Chennai Meenakshi Multis… CMMHOSP -7.62 ₹27 Low
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹39 Low
Krebs Biochemicals & Ind… KREBSBIO -0.75 ₹128 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.18 ₹43 Low